People

Researchers, students and alumni of YAS Lab.

Principal investigator

Yao-An Shen, PhD

Yao-An Shen, PhD

Associate Professor · Department of Pathology / Graduate Institute of Clinical Medicine / International Master/PhD Program in Medicine, College of Medicine, Taipei Medical University

Dr. Yao-An Shen graduated with first-class honors from the PhD program in Biochemistry and Molecular Biology at National Yang-Ming University, Taiwan. His passion for cancer research led him to Johns Hopkins University for postdoctoral training, where he specialized in cancer stem cells (CSCs) and translational research.

Determined to bridge fundamental science and clinical applications, he focused on unraveling the mechanisms of CSCs – a chemoresistant, recurrent, and metastatic tumor subset. His mission is to develop innovative therapeutic strategies, spanning immune cell therapy, transcription factor inhibitors, and nanomedicine.

Dr. Shen's work has earned him membership in Sigma Xi and nine Young Investigator Awards. He has published in journals such as Blood, ACS Nano, Cancer Research, EBioMedicine, J Exp Clin Cancer Res, and Cell Reports. Beyond academia, he holds over 10 patents in cell therapy, small molecule drugs, vesicular drugs, and nanoparticle drugs. In 2024, he founded Enlighten Biomedicine, a biotechnology company translating CSC research into medical applications.

As an associate professor at Taipei Medical University, he continues to advance cancer stem cell research and the development of next-generation oncology treatments.

Education

  • 2009–2015PhD, Institute of Biochemistry and Molecular Biology, National Yang-Ming University
  • 2007–2009MS, Department of Life Sciences and Institute of Genome Sciences, National Yang-Ming University
  • 2000–2004BS, Department of Life Science, Tzu Chi University

Research specialties

  • Translational Research — Small molecule inhibitors targeting GLS and PBX1 as cancer therapeutics
  • Cell Therapy — Stem cells for regenerative medicine and immune cells for anti-cancer therapy
  • Cancer Metabolism — Metabolic compensation and the microenvironmental landscape of therapy-resistant cells
  • Cancer Stem Cell Research — Metabolic reprogramming of cancer stem cells and biomarker discovery for targeted therapy
  • Induced Pluripotent Stem Cells — Metabolic reprogramming and anti-cancer applications of iPSCs
  • Nanomedicine — Targeted delivery systems of nanobiomaterials for cancer stem cell treatment

Experience

  • 2024.02–presentAssociate Professor, Department of Pathology / Graduate Institute of Clinical Medicine / International Master Program in Medicine, Taipei Medical University
  • 2019.06–2024.02Assistant Professor, Department of Pathology / Graduate Institute of Clinical Medicine / International Master Program in Medicine, Taipei Medical University
  • 2016.08–2019.06Postdoctoral Fellow, Departments of Pathology, Oncology, and Gynecology & Obstetrics, Johns Hopkins Medical Institutions, Baltimore, MD, USA
  • 2015.08–2016.07Postdoctoral Fellow, Department of Biomedical Engineering, National Yang-Ming University
  • 2015.02–2015.07Postdoctoral Fellow, Section of Gynecologic Oncology, Department of Obstetrics and Gynecology, Taipei Veterans General Hospital

Teaching

General Biology, General Chemistry, Biochemistry and Molecular Biology, Molecular Pathology, Genetics, Bioenergetics and Metabolism, Cancer Stem Cell Biology, Stem Cell Biology, Translational Medicine, Development of Cancer Therapeutics, Problem-Based Learning, Critical Thinking and Research Design

Grants (10)

  • 2025.01–2029.12PI — Development of Acid-Responsive Mesoporous Silica Nanoparticles for Delivery of PBX1 Inhibitors Targeting Cancer Stem Cell Transcriptional ActivityNational Health Research Institutes (NHRI-EX114-11404E1)
  • 2024.08–2028.07PI — Utilizing Glucosamine-Labeled Nanodrugs as a Novel Pancreatic Cancer Stem Cell Therapy to Counteract Metabolic Compensation and Synergistically Inhibit Transcriptional ActivityNational Science and Technology Council (NSTC 113-2628-B-038-012)
  • 2024.01–2024.12PI — Commercial Applications of Technique Platform Development for Cancer Stem Cell Isolation and Cell TherapyNational Science and Technology Council (NSTC 113-2823-8-038-001)
  • 2023.08–2024.07PI — Investigation on the Synergistic Effect of a Combination of PCSK9 Inhibitors and Hyperthermia in Hepatic Cancer Stem CellsNational Science and Technology Council (NSTC 112-2314-B-038-081)
  • 2023.01–2023.12PI — Technique Platform Development for Cancer Stem Cell Isolation and Cell TherapyNational Science and Technology Council (NSTC 112-2823-8-038-001)
  • 2022.08–2023.07PI — Development of First-in-class Transcription Factor Drug Targeting Cancer Stem CellsNational Science and Technology Council (NSTC 111-2622-B-038-008)
  • 2021.04–2022.04Co-PI — Investigation of Hyperthermia Effects on Tumor Metabolism and Microenvironment in Radioresistant Bladder CancerTaipei Medical University Hospital (110TMU-TMUH-02-2)
  • 2020.12–2023.11PI — Investigation of Metabolic Isolation of Stem Cells and Its Effects on Differentiation Therapy of Cancer Stem CellsI CARE YOU Biotech (A-109-084)
  • 2020.02–2022.07PI — Reversing Metabolic Compensation to Overcome Recurrence in Ovarian Cancer by Inhibition of MYC/GLS AxisMinistry of Science and Technology (MOST 109-2314-B-038-021-MY3)
  • 2019.09PI — Research Grants for Newly Hired FacultyTaipei Medical University (TMU108-AE1-B12)

Honors & awards (14)

  • 2024.08Elected full member of Sigma Xi, the Scientific Research Honor Society
  • 2023.05Licensing & technology transfer of 8 patents on cell expansion and metabolic selection techniques (I CARE YOU Biotech)
  • 2016.11Postdoctoral Research Abroad Program (PRAP) Award, Ministry of Science and Technology, Taiwan
  • 2013.11Young Investigator Award, International Symposium on Mitochondria 2013 / 13th Conference of J-mit, Japan
  • 2013.11Young Investigator Award, 10th Conference of the Asian Society of Mitochondrial Research and Medicine (ASMRM), Korea
  • 2013.10First Prize, Poster Award, 2013 Mini-symposium on Mitochondria and Aging, Taiwan
  • 2013.10Young Investigator Award, 6th Biennial Meeting of SFRR-Asia, Taiwan
  • 2013.09Third Prize, Poster Award, 2013 International Symposium on Mitochondrial Dynamics in Translational Medicine, Taiwan
  • 2012.11Young Investigator Award, 9th ASMRM Conference, Beijing, China
  • 2012.10Silver Medal, Oral Session Competition, 7th International Symposium on Genomic Medicine of CCH, Taiwan
  • 2011.10Fellowship Award, 22nd FAOBMB Conference, Singapore
  • 2011.08Young Investigator Award, 8th ASMRM Conference, Kagoshima, Japan
  • 2011.07First Prize, Poster Award, 2011 Mackay International Symposium on Mitochondrial Medicine, Taipei, Taiwan
  • 2010.12Young Investigator Award, 7th ASMRM Conference, Fukuoka, Japan

Patents (5)

  • 2024.12A method for expanding circulating tumor cells and applications thereofTaiwan I865391
  • 2024.10Cancer stem cell serum-free conditioned medium, and use thereof in a quadruple selecting method for cancer stem cell line, and the isolated cancer stem cell lineTaiwan I858897
  • 2024.09PRP-plus and its preparation method and useTaiwan I856429
  • 2024.05Peripheral blood stem cell amplification methodTaiwan I843445
  • 2021.08Monosaccharide-tagged nano-liposome drug delivery system, the manufacture and use for drug targeting delivery thereofTaiwan I734987; PCT/CN2019/088142

Current members

Current members

Staff 4

  • Hung-Chung Chang

    Postdoctoral Fellow

    Business Development

  • George Cheng

    Researcher

    R&D

  • Ho Thi Luu

    Postdoctoral Fellow

  • Kyle Cheng

    MD

    R&D

Graduate Students 7

  • Ray Chang

    PhD Student

  • Yuyu Rahayu Arifin

    PhD Student

  • Dinesh Kute

    PhD Student

  • Eman Fatima

    PhD Student

  • Yuki

    PhD Student

  • Nguyen Dinh Thien

    PhD Student

  • Jamie Lin

    MS Student · Lab Manager

Medical Students 12

  • Allison莊晰之

    Medical Student

  • Albert吳道賢

    Medical Student

  • Heidi李彩禕

    Medical Student

  • Tiffany曾馨儀

    Medical Student

  • Angelina陳安晴

    Medical Student

  • Mina洪子宸

    Medical Student

  • Mimi楊岱穎

    Medical Student

  • Amber林詠芯

    Medical Student

  • Maus陳竤宇

    Medical Student

  • Andy許和晏

    Medical Student

  • Anna楊詠晴

    Medical Student

  • Keynes邱楷恩

    Medical Student

Alumni

Alumni

  • Ho Thi Luu

    PhD Program

    2022–2026

    NowPostdoctoral Fellow at YAS Lab

  • Viet-Cuong Nguyen

    PhD Program

    2023–2026

    Now—

  • Jane Tien Phan

    Master's Student

    2023–2025

    Now—

  • Liang-Yun Chen

    Medical Student

    2023–2025

    NowPGY at SHH

  • Ting-Wan Kao

    Master's Student

    2023–2024

    NowMaster's student at Harvard Medical School

  • Geng-Hao Bai

    Medical Student

    —

    NowResident at NTUH